Efficacy of tDNA Care on Weight Loss and Metabolic Outcomes in Patients With Overweight, Obesity and Type 2 Diabetes
The Efficacy of a Transcultural Diabetes Nutrition Algorithm (tDNA) Care on Weight Loss and Metabolic Outcomes in Patients With Overweight, Obesity and Type 2 Diabetes in an Outpatient Clinic Setting
1 other identifier
interventional
230
1 country
1
Brief Summary
The aim of this study was to investigate the effectiveness of structured lifestyle intervention following a transcultural diabetes nutrition algorithm (tDNA) care compared to usual diabetes care in patients with overweight, obesity and type 2 diabetes (T2D), receiving either the motivational interviewing counseling or conventional counselling technique in an outpatient clinic setting. The hypothesis is weight loss and glycated haemoglobin (A1C) level will be improved in patients following the tDNA care compared to usual diabetes care and the improvements will be greater in those receiving motivational interviewing counseling than conventional counselling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Jun 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 12, 2019
CompletedFirst Posted
Study publicly available on registry
March 19, 2019
CompletedMarch 22, 2019
March 1, 2019
1.5 years
March 12, 2019
March 20, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Weight
Anthropometry
6 months, 12 months
Change in Glycated haemoglobin (A1C)
Biochemical measure
6 months, 12 months
Secondary Outcomes (8)
Change in percentage body fat
6 months
Change in fasting blood glucose
6 months
Change in total cholesterol, LDL-C and HDL-C
6 months
Change in High sensitivity C-Reactive Protein (HsCRP)
6 months
Change in systolic and diastolic blood pressure
6 months
- +3 more secondary outcomes
Study Arms (3)
tDNA-MI group
ACTIVE COMPARATORFollow tDNA intervention and motivational interviewing counselling
tDNA-CC group
ACTIVE COMPARATORFollow tDNA intervention and conventional counselling
UC group
OTHERFollow a conventional diet with standard diabetes support and lifestyle education
Interventions
tDNA care with structured low calorie meal plan of 1200-1500 kcal/day with conventional foods + 1-2 serving of diabetes specific meal replacements and motivational interviewing counseling. .
tDNA care with structured low calorie meal plan of 1200-1500 kcal/day with conventional foods + 1-2 serving of diabetes specific meal replacements+ 150 min/week of moderate intensity exercise + and conventional counselling.
Meal plan of 1200-1500 kcal/day using conventional foods + 150 min/week of moderate intensity exercise + and conventional counselling
Eligibility Criteria
You may qualify if:
- Diagnosed with type 2 diabetes mellitus, requiring weight loss
- Treated with oral hypoglycaemic medications and/or lifestyle modifications
- Medications have been optimised with no changes in pharmacotherapy in the past three months
- Aged between 30 to 65 years
- BMI of \>23 kg/m²
- A1C between 7% to 9%
- Failed to achieve HbA1c reduction in the past three months even after seeing a dietitian
- Willing to comply with study procedures.
You may not qualify if:
- Patients whom weight loss might not be safe
- Patients diagnosed with type 1 diabetes mellitus and type 2 diabetes mellitus with basal or multiple insulin injections
- Patients with weight loss exceeding 5 kg in the past three months
- Patients with current use of medications/meal replacements for weight loss
- Patients with cancer requiring treatment for the past five years, except of non-melanoma skin cancers or cancers that have been clearly cured
- Patients with history of bariatric surgery, small bowel resection, or extensive bowel resection
- Patients with cardiovascular disease (heart attack or procedure within past three months or participation in cardiac rehabilitation program within last three months, stroke or history/treatment for transient ischaemic attacks in the past three months, or documented history of pulmonary embolus for the past six months)
- Patients with renal disease with eGFR \<60 ml/min (based on MDRD) or currently receiving dialysis
- Patients with chronic alcoholism
- Patients who are currently pregnant or nursing
- Patients who plan to relocate where it does not permit full participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
International Medical University
Kuala Lumpur, 57000, Malaysia
Related Publications (1)
Gilcharan Singh HK, Chee WSS, Hamdy O, Mechanick JI, Lee VKM, Barua A, Mohd Ali SZ, Hussein Z. Eating self-efficacy changes in individuals with type 2 diabetes following a structured lifestyle intervention based on the transcultural Diabetes Nutrition Algorithm (tDNA): A secondary analysis of a randomized controlled trial. PLoS One. 2020 Nov 30;15(11):e0242487. doi: 10.1371/journal.pone.0242487. eCollection 2020.
PMID: 33253259DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Winnie SS Chee, PhD
IMU University, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 12, 2019
First Posted
March 19, 2019
Study Start
June 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 22, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share